4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-20-043224
Options or other derivatives
- CEO, Pres, CFO, Treas & Secy acquired 450,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KENYON LAWRENCE A · CEO, Pres, CFO, Treas & Secy
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-07-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +450,000 | 450,000 | D |
Loading xslF345X03/doc4.xml…